💰 CRM $14M LEAP Put SALE — Someone's Getting Paid to Agree to Own Salesforce Near $150!

📅 July 13, 2026 | 🔥 Unusual Activity Detected

✅ Updated July 14, 2026 — OI RESOLVED. The next-day OPRA open-interest snapshot confirms the read HELD: OI rose 155 → 4,004 (+3,849 vs. a 3,900-lot trade**)**, proving STO — sold to OPEN a fresh short-put position. See the ✅ RESOLVED box below.

---

🎯 The Quick Take

Someone just collected $14 MILLION in cash selling 3,900 deep in-the-money June 2027 $185 puts on Salesforce (CRM) — a nearly year-long bet that a stock already down ≈33% YTD doesn't keep falling. This isn't a bearish bomb dropping; it's a synthetic-long, get-paid-to-buy-the-dip structure on a beaten-down mega-cap with a $50B buyback shrinking the float underneath it. Translation: a big player is willing to own Salesforce near $150 a share — and got paid handsomely up front for agreeing to it.

---

📊 Company Overview

Salesforce, Inc. (CRM) is the world's #1 customer relationship management (CRM) platform and one of the largest enterprise cloud software companies on the planet:

• Market Cap: ≈$165 Billion
• Industry / Sector: Application Software — Enterprise Cloud / Prepackaged Software
• Current Price: ≈$170.7 (trade printed at $172.55)
• Primary Business: Cloud-based CRM (Sales Cloud, Service Cloud, Marketing Cloud), Slack, Tableau, MuleSoft, and — the newest growth engine — Agentforce, its agentic-AI platform that lets enterprises deploy autonomous AI agents on top of their CRM data

Salesforce is in the middle of a tug-of-war: it's compounding double-digit revenue with record margins, but the market is terrified that agentic AI eventually cannibalizes the seat-license business model that built the company. That fear is exactly why the stock is this cheap.

---

💰 The Option Flow Breakdown

📊 What Just Happened

The Tape (July 13, 2026 @ 12:26:10):

🤝 BLOCK CROSS — this printed 20% across the bid/ask (near the bid), which is the signature of a negotiated block cross: one broker matched a known buyer and a known seller off the open book, not an aggressive sweep tearing through the order book. Read it as deliberate, pre-arranged institutional positioning — not panic selling.

✅ RESOLVED — Next-Day OI Confirms: STO (Sold to OPEN) — Read HELD

Resolved 2026-07-14 from the ≈06:30 ET OPRA open-interest snapshot. This box replaces the ⏳ provisional flag published on July 13.

We predicted OI would jump from 155 toward ≈4,055. It printed 4,004 — a +3,849 increase against a 3,900-lot trade, or ≈99% of the full size as brand-new contracts. Almost nothing here was a transfer between existing holders; this line was genuinely created on July 13.

Verdict: the read HELD, and the order type is now confirmed rather than inferred. This is STO — sold to open: a fresh, live short-put position running to June 2027. Someone collected ≈$14M in premium and is now genuinely on the hook to buy Salesforce at $185 (≈$150 net of the premium) if it's below that strike in eleven months. Nothing about the original thesis changes — it is simply now proven by open interest rather than implied by size.

---

🤓 What This Actually Means — Plain English

Selling a put means getting paid cash today in exchange for agreeing to buy the stock at the strike price if it's below that strike at expiration. Here's the math on this one:

• 💵 $34.95 collected per contract × 3,900 contracts × 100 shares = $14.0M cash in the seller's pocket, today
• 📉 Effective purchase price if assigned: $185 strike − $34.95 premium collected = ≈$150 per share — that's ≈13% BELOW today's $172.55 spot, and remarkably close to where CRM's stock actually bottomed back in June 2026
• 🧮 The $185 strike is already deep in-the-money (spot $172.55 is $12.45 below it), so ≈$12.45 of that $34.95 is "already there" intrinsic value, and the real time premium being sold is the remaining ≈$22.50
• ⏰ Nearly 1 year to expiration (June 17, 2027) — this is a patient, multi-quarter position, not a quick trade
• 📦 Total notional exposure: if CRM is below $185 at expiration, the seller is on the hook to buy 390,000 shares (3,900 contracts) — a ≈$72M commitment at the strike, offset by the $14M already collected

What this structurally means: selling a deep ITM put is functionally a synthetic long position — the seller profits if CRM stays flat or rises (keeps the full $14M), and only starts losing money if CRM falls significantly below ≈$150 by mid-2027. It's a bullish-to-neutral, income-generating financing trade, not a bearish bet. Think of it like getting paid a $14M "signing bonus" to promise you'll buy a house at a discount to today's price if the seller ever wants to sell it to you.

One honest limit: because this printed as a cross, we can see the trade — but we cannot see the customer's full book. We don't know if this is a fund monetizing an existing bullish view, a bank facilitating someone else's trade, or part of a larger multi-leg structure that isn't visible on the option tape alone. Graded confidence: mechanism (block cross) and open/close (fresh open) are PROVEN from the tape. The "bullish-lean, synthetic-long" read on intent is INFERRED from the structure — reasonable, but not provable from a single print.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

CRM has been brutal in 2026 — down -32.66% YTD, from a $253.62 start to ≈$170.79 today, with a max drawdown of -43.59%. The chart shows a steady bleed from January through mid-June (bottoming near $150-151 in mid-June), a sharp relief spike in early June, then a grind higher back toward $170 over the past month.

Key observations:

• 📉 Persistent downtrend: Nearly a straight line lower from January's $253 through June's ≈$150 low — this is a stock the market has been actively de-rating all year
• 🎯 The June low (≈$150) IS the put seller's effective ownership price — not a coincidence worth ignoring
• 📈 Recent stabilization: CRM has climbed off the June lows, up roughly 13% from the ≈$150 bottom
• 🎢 Volatility: 25.01 annualized — much calmer than a high-flying momentum name, consistent with a "value/income" setup rather than a lottery ticket
• 📊 Volume spike mid-June coincides with the low — capitulation-style volume often marks at least a near-term floor

Gamma-Based Support & Resistance Analysis

Current Price: ≈$170.66

🔵 Support Levels (Put Gamma Below Price):

• $170 — Immediate support, Very Strong (21.3B total gamma — the single largest level on the board, sitting right at spot)
• $165 — Secondary support, Very Strong (11.6B gamma)
• $160 — Structural floor, Very Strong (12.8B gamma)
• $150 — Deeper support zone visible in the gamma history (matches the put seller's effective ≈$150 ownership price almost exactly)

🟠 Resistance Levels (Call Gamma Above Price):

• $175 — Immediate ceiling, Very Strong (13.6B gamma)
• $180 — Major resistance, Very Strong (14.6B gamma)

What this means for traders: CRM is pinned in a tight, well-defined range between $165-170 support and $175-180 resistance right now. Dealers holding large gamma positions at $170 and $180 tend to dampen big moves in between — expect chop until a catalyst (like the August 26 earnings) breaks the range. Notice the $150 level lighting up as a real historical support zone — exactly where this put seller is effectively agreeing to buy the stock. That's not lucky strike selection; it's a level the market has already respected once this year.

Implied Move Analysis

Options market pricing for upcoming expirations:

• 📅 Monthly OPEX (Jul 17 — 4 days): ±5.14% (±$8.77) → Range: $161.98 - $179.52
• 📅 Weekly (Jul 24 — 11 days): ±8.28% (±$14.14) → Range: $156.61 - $184.89
• 📅 The LEAP band (Jun 2027, near this put's own expiration): the options market is pricing a WIDE range by then — roughly $96 - $245 by the June 2027 triple-witch, reflecting nearly a year of accumulated uncertainty

Translation for regular folks: In the next week and a half, the market thinks CRM stays roughly between $157 and $185 — right around the $185 strike this put was sold at. But zoom out to where this contract actually expires (June 2027), and the market is pricing a massive range because so much can happen in 11 months: two more earnings reports, the fate of Agentforce monetization, and the broader AI-disruption debate. The put seller doesn't need CRM to rally to that $245 upper bound — they just need it to stay above ≈$150 to keep the full $14M.

---

🎪 Catalysts

✅ Recent Catalysts (Last 3 Months)

Q1 FY2027 Earnings — Reported May 27, 2026 📊

Salesforce delivered record Q1 results: revenue of $11.13B, up 13% YoY, with non-GAAP EPS of $3.88, up 50% YoY — smashing the ≈$2.96 Street estimate. Margins hit record levels: GAAP operating margin 21.1%, non-GAAP 34.8% (10-Q filing). Current RPO (forward revenue backlog) grew 14% to $33.6B.

The blemish keeping the stock cheap: billings grew only ≈+3.6% YoY — the number the AI-disruption bears point to as evidence that seat-based growth is stalling (StoxCraft analysis).

Agentforce Crosses $1.2B ARR 🤖

Agentforce ARR hit $1.2B, up 205% YoY — combined with Data 360, total AI-platform ARR is now ≈$3.4B, up 200% YoY. Nearly 29,000 Agentforce deals have closed since launch. This is the core bull case: AI is expanding Salesforce's revenue base, not just cannibalizing it.

Informatica Deal Closed Early 🔗

The ≈$8B Informatica acquisition closed in mid-November 2025, ahead of schedule, and is already contributing (≈$428M in Q1 FY27 revenue) — adding data governance and integration muscle that feeds directly into Agentforce.

Massive Debt-Funded Buyback 💰

Salesforce authorized a $50B repurchase program and priced $25B in senior notes in March 2026 specifically to fund an accelerated share repurchase. Q1 FY27 alone saw ≈$27.5B returned to shareholders — the company is aggressively shrinking its share count into the 2026 selloff, a mechanical floor-building dynamic that's directly supportive of the put seller's near-$150 ownership level.

Mixed Analyst Reaction: Guggenheim upgraded to Buy with a $228 target on July 1, while Bank of America holds Underperform at a $160 price target on the AI-cannibalization thesis. Consensus across ≈34 analysts remains Buy, with an average target near $260 — a huge gap above today's ≈$172.55.

🔮 Upcoming Catalysts (Next 6 Months)

Q2 FY2027 Earnings — Wednesday, August 26, 2026 (after market close) 📅

This is THE catalyst standing between now and the near-dated implied-move windows. Guidance calls for revenue of $11.27B-$11.35B (+10-11% YoY), with FY27 framed at $45.9B-$46.2B revenue. The billings/cRPO trajectory and Agentforce ARR growth rate are the two numbers that matter most — a re-acceleration validates the bullish/financing thesis behind this put sale, while another soft billings print is the primary path toward the stock testing (or breaking) that ≈$150 level.

Ongoing ASR Execution 🔄

The $25B debt-funded buyback continues reducing share count through the rest of 2026 — a persistent EPS tailwind and demand floor under the stock.

Agentforce Monetization Ramp 🚀

Continued deal counts, Agentic Work Unit growth, and Data 360 consumption trends will be the swing factors that could re-rate the stock's multiple if they convert into visible reported revenue growth.

Q3 FY2027 Earnings is expected late November / early December 2026 (date not yet confirmed) — falls just inside the 6-month window and would be the next major read on the AI-monetization inflection before this put's June 2027 expiration.

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and the catalyst calendar, here's how this plays out through the June 17, 2027 expiration:

📈 Bull Case (35% probability)

Target: $200-$260 (toward analyst consensus)

Agentforce ARR keeps compounding at triple-digit growth, Q2 and Q3 FY27 show billings re-acceleration, and the $50B/$25B buyback keeps mechanically shrinking the float. CRM re-rates back toward its ≈$260 average analyst target. In this scenario, the put expires worthless — the seller keeps the entire $14.0M, no shares change hands. This is the outcome the trade is structured to profit most cleanly from.

🎯 Base Case (45% probability)

Target: $160-$195 (choppy consolidation)

CRM continues trading in the range the gamma chart already shows — bouncing between $160-165 support and $175-180 resistance as the market digests mixed billings data against a genuinely strong AI growth story. By expiration, CRM could land anywhere from modestly above to modestly below $185. This is where the put seller's skill matters most — even a small dip below $185 near expiration still leaves plenty of the $14.0M credit intact if CRM stays well above the ≈$150 breakeven.

📉 Bear Case (20% probability)

Target: Below $150 (tests the breakeven)

The AI-cannibalization bear case plays out: billings decelerate further, Agentforce growth slows, and Bank of America's $160 bear thesis (or worse) becomes consensus. CRM revisits or breaks its June 2026 low near $150-151. This is where the put seller actually starts losing money — below ≈$150, they're effectively long CRM stock at a worse price than they'd hoped, having been assigned 390,000 shares at $185 against a $14.0M cushion.

Put seller's P&L sketch (per contract, at June 2027 expiration):

• CRM at $200: put expires worthless, seller keeps full $34.95 premium (100% of credit)
• CRM at $170: put worth ≈$15 intrinsic, seller nets ≈$19.95/contract profit (≈57% of credit retained)
• CRM at $150: put worth $35 intrinsic, seller roughly breaks even (≈$0.05/contract)
• CRM at $120: put worth $65 intrinsic, seller loses ≈$30.05/contract (≈$11.7M loss on the full position) while owning stock at an effective $150 cost basis in a $120 tape

---

🎭 How Different Traders Should Read This

🎲 YOLO Trader

Replicating a $14M, 3,900-contract institutional put sale isn't realistic for a retail account — the collateral alone (≈$72M notional) is out of reach. If you want the aggressive, high-convexity version of "I think CRM is cheap here," the YOLO play is a small number of short-dated, out-of-the-money Aug 21 or Sep 18 calls sized to survive a total loss, timed around the August 26 earnings print for a billings-beat pop. This is a directional bet with a real chance of going to zero — size it like lottery tickets, not a core position.

Risk level: Extreme (can lose 100% of premium) | Skill level: Advanced only

📈 Swing Trader

Trade the gamma range this trade is implicitly betting will hold. Buy dips toward the $165 support zone (11.6B gamma) targeting the $175-180 resistance band (13.6B-14.6B gamma), using a defined-risk call debit spread (e.g., buy the $170 call, sell the $180 call, expiring after the August 26 earnings) rather than naked shares if you want leverage with capped downside. Exit into strength at resistance; don't chase above $180 without a fresh catalyst.

Risk level: Moderate (defined risk, range-bound) | Skill level: Intermediate

💵 Premium Collector (Closest to This Actual Trade)

This is your persona — the $14M trade IS a premium-collection strategy, just at institutional scale. The retail-sized version: instead of a naked $185 put (which demands ≈$18,500 in cash-secured collateral per contract), use a put credit spread that mirrors the same bullish-lean thesis with far less capital at risk — for example, sell the $160 put / buy the $150 put expiring around the same June 2027 window, collecting a modest net credit while capping max loss at the $10-wide spread minus the credit received. You're betting CRM stays above $160 over the next year — a far less aggressive strike than the $185 in this trade, but the same "get paid to agree to own it lower" logic.

Risk level: Moderate (defined max loss with a spread) | Skill level: Intermediate

🌱 Beginner

The concept here is simple even if the size is scary: selling a put means you're getting paid cash today in exchange for a promise — if the stock falls below your strike, you have to buy it there. It's genuinely how you can "get paid to buy a dip" instead of just placing a limit order and waiting for free.

Start tiny. If you already like CRM and wouldn't mind owning it at $150, consider selling 1 cash-secured put (not 3,900!) at a strike you're actually comfortable owning the stock at, with an expiration a few months out rather than a full year. Understand you WILL be assigned 100 shares if the stock is below your strike at expiration — that's not a bug, it's the whole point of the trade. Never sell a put on a stock you wouldn't want to own.

Risk level: Low if sized to 1 contract on a stock you want | Skill level: Beginner-friendly (but requires understanding assignment)

---

⚠️ Risk Factors & Honest Limits

What the tape proves, and what it can't:

• ✅ PROVEN: Mechanism (block cross, negotiated off-book), size (3,900 contracts), premium ($14.0M credit), and open/close (fresh open — size is 25x prior OI of 155).
• 🤔 INFERRED, not proven: That this is a bullish/financing position rather than, say, part of a larger multi-leg structure we can't see on a single-leg print. Deep ITM put sales are structurally synthetic-long, but a cross can't tell us the seller's full portfolio context.
• ❓ UNKNOWABLE from OPRA data: The broker or firm behind the trade, the counterparty's identity, whether the seller has an offsetting stock or futures hedge elsewhere, and whether this cross is one leg of a bigger strategy executed across multiple venues or days.

Other risks to weigh:

• ⏰ Nearly a full year of event risk: Two more earnings reports (Aug 26, 2026 and one in late 2026) sit between now and expiration — plenty of time for the AI-cannibalization debate to resolve either direction.
• 📉 Valuation is cheap for a reason: Billings growth of only ≈3.6% is a real red flag that the seat-license model may genuinely be under pressure — this isn't a slam-dunk value trap call.
• 💸 Leverage on the buyback: The $25B debt-funded ASR roughly halved FCF guidance for the year — it's a real tailwind for EPS and share count, but it does add balance-sheet leverage.
• 🎢 A cross doesn't confirm urgency or conviction: Unlike a lit sweep that has to pay up through the offer, a block cross is a negotiated price — it tells us less about how badly either side wanted the trade.
• 🏦 Size like an institution can't be replicated at retail — the $72M notional exposure behind this trade requires resources far beyond a typical retail account; use the smaller structures above instead of trying to mirror the size.

---

🎯 The Bottom Line

Real talk: Someone just got paid $14 million in cash to agree to own Salesforce near $150 a share — roughly 13% below today's price — over the next year. That's not a bearish signal on CRM; it's a patient, income-generating bet that a stock already down ≈33% YTD has more support than downside from here, backed by a company that's still growing revenue at double digits with record margins and an AI product (Agentforce) scaling at 200%+ ARR growth.

What this trade tells us:

• 🎯 A sophisticated player is comfortable owning CRM near ≈$150 — right at the stock's actual June 2026 low and a real gamma support zone
• 💰 They collected $14.0M up front, a meaningful cushion before this position starts losing money
• ⏰ The nearly year-long horizon (through June 2027) captures two more earnings reports where the Agentforce-vs-billings debate should start to resolve
• 📊 The strike sits right at the top of the near-term implied-move range ($185 vs. the $179.52 upper bound for this Friday's OPEX) — near-term, the market doesn't expect a violent move either way

If you own CRM: this trade is a vote of confidence from at least one sophisticated player that the worst of the selloff may be behind the stock — but the soft billings number is real, so don't ignore risk management into the August 26 earnings print.

If you're watching from the sidelines: the $165-170 support zone is the area to watch for entries with defined risk; wait for August 26 earnings clarity on billings before sizing up meaningfully.

If you're bearish: the $160 level is your line in the sand — a break below it with volume would open the door back toward the $150 zone, which is exactly where this put seller starts feeling real pain.

Mark your calendar:

• 📅 July 17, 2026 — Monthly OPEX (near-term implied move window)
• 📅 August 26, 2026 (after close) — Q2 FY2027 earnings, the next big catalyst
• 📅 Late Nov / Early Dec 2026 — Q3 FY2027 earnings (date TBD)
• 📅 June 17, 2027 — Expiration of this $14.0M put trade

Final verdict: Salesforce's AI transformation story remains genuinely compelling — record margins, an Agentforce franchise growing over 200% YoY, and a debt-funded buyback machine shrinking the float into weakness. The soft ≈3.6% billings growth is the real crack in the bull case and the reason the stock is this cheap. This $14M put sale is a bet that the crack doesn't turn into a break — and it's structured to profit whether CRM goes up, sideways, or drifts modestly lower, only truly hurting if the stock revisits its 2026 lows.

Be patient, watch the $160-170 zone, and let the August 26 billings number tell you which way this resolves. 💪

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. Selling puts — especially deep in-the-money, multi-year LEAP puts — carries the obligation to buy shares at the strike price and can result in losses significantly larger than the premium collected if the stock falls sharply. This specific trade's size and structure are unusual relative to typical CRM options flow, but that alone does not imply the trade will be profitable or that you should follow it at any size. Always do your own research and consider consulting a licensed financial advisor before trading. The put seller may have complex portfolio hedging or financing needs not applicable to retail traders.

---

Last updated: July 14, 2026 — the next-day OPRA open-interest snapshot resolved the open/close flag. OI rose 155 → 4,004 (+3,849 vs. a 3,900-lot trade, ≈99% brand-new contracts), confirming STO (sold to open). The read HELD — no change to the thesis, tone, or title. The provisional ⏳ callout published on July 13 has been replaced with the ✅ RESOLVED box above.

---

About Salesforce, Inc.: Salesforce is the world's leading provider of cloud-based customer relationship management (CRM) software, with a growing portfolio spanning Sales Cloud, Service Cloud, Marketing Cloud, Slack, Tableau, MuleSoft, and its fast-scaling agentic-AI platform Agentforce, with a market cap of ≈$165 billion in the Application Software / Enterprise Cloud industry.